Sildenafil Tablet
Product Images NDC 55801-339

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 55801-339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Appco Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-6.jpg (Fig 6)

Two bar charts illustrating the effect of SILDENAFIL tablets and placebo on the maintenance of erection by baseline score. The x-axis represents baseline scores 0 to 5, and the y-axis shows the percentage of patients at endpoint up to 80%. The first chart shows data for SILDENAFIL with increasing percentages at higher scores, while the second shows varied placebo effects across baseline scores. Both charts use a legend with categories labeled 0 to 5.*

FDA Label Image

Fig5 (Fig5)

A pharmacokinetic curve chart showing plasma concentration (ng/mL) of a drug over time post-dose (hours). The graph depicts the decline in plasma concentration from an initial peak, illustrating the drug's absorption and elimination phases after oral administration of a commercial tablet.*

FDA Label Image

Figure-7.jpg (Figure 7)

A bar graph showing the percentage of patients reporting improvement across treatment groups: placebo, sildenafil 25 mg, sildenafil 50 mg, and sildenafil 100 mg tablets. The percentages increase from 24% with placebo to 82% with sildenafil 100 mg tablets, illustrating a dose-dependent response.*

FDA Label Image

Figure1 (Figure1)

A line graph depicting systolic blood pressure changes over 24 hours post-dose. The x-axis represents time in hours, and the y-axis shows systolic blood pressure in mmHg. Two lines compare effects of SILDENAFIL 100 mg and placebo across the time points.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the change in systolic blood pressure (SBP) over time (hours) postdose. Two lines compare Doxazosin plus placebo versus Doxazosin plus Sildenafil 25 mg, showing their respective effects on SBP from 0 to 8 hours postdose.*

FDA Label Image

Figure3 (Figure3)

A line graph comparing the change in EDV (ml/G) over time postdose (hours) for two treatments: Doxazosin with Placebo and Doxazosin with Sildenafil 50 mg. The graph shows data points from 0 to 8 hours, illustrating differences in EDV changes between the two groups.*

FDA Label Image

Figure4 (Figure4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes in mmHg over time in hours after dosing. Two lines compare Doxazosin plus Sildenafil 100 mg and Doxazosin plus Placebo, illustrating blood pressure change trends over an 8-hour period.*

FDA Label Image

Sildenafil-spl-100mg-500s (Sildenafil Spl 100mg 500s)

Label for Sildenafil Tablets, USP 100 mg oral tablets by Appco Pharma LLC. The label states storage instructions, dispensing details, and that each film-coated tablet contains sildenafil citrate equivalent to 100 mg sildenafil. It indicates a prescription-only status with a package count of 500 tablets.*

FDA Label Image

Sildenafil-spl-25mg-500s (Sildenafil Spl 25mg 500s)

Label for Sildenafil Tablets, USP 25 mg oral tablets by Appco Pharma LLC. The label includes storage instructions, dosage notes, a barcode, and indicates a package quantity of 500 tablets. The label also notes the product is Rx only and contains 25 mg sildenafil citrate per tablet.*

FDA Label Image

Sildenafil-spl-50mg-500s (Sildenafil Spl 50mg 500s)

Label for Sildenafil Tablets, USP 50 mg, in a package containing 500 tablets. The label includes storage instructions, dosage information, and indicates the product is prescription only. Manufactured and distributed by Appco Pharma LLC, Piscataway, NJ. The label features a barcode and the Appco Pharma logo.*

FDA Label Image

Sildenafil-spl-appco-logo (Sildenafil Spl Appco Logo)

FDA Label Image

Str (Structure)

Chemical structure of sildenafil shown as a two-dimensional diagram highlighting its molecular components and arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.